Rachna Shroff, MD

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Bayer
    Topic:
    Cancer
    Date added:
    12/02/2021
    Date updated:
    12/02/2021
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    BMS
    Topic:
    Cancer
    Date added:
    12/02/2021
    Date updated:
    12/02/2021
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Bristol-Myers
    Topic:
    Cancer
    Date added:
    12/02/2021
    Date updated:
    12/02/2021
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Exelixis
    Topic:
    Cancer
    Date added:
    12/02/2021
    Date updated:
    12/02/2021
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    IMV Inc.
    Topic:
    Cancer
    Date added:
    12/02/2021
    Date updated:
    12/02/2021
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    LOXO
    Topic:
    Cancer
    Date added:
    12/02/2021
    Date updated:
    12/02/2021
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Novocure
    Topic:
    Cancer
    Date added:
    12/02/2021
    Date updated:
    12/02/2021
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    NUCANA
    Topic:
    Cancer
    Date added:
    12/02/2021
    Date updated:
    12/02/2021
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Rafael Pharm.
    Topic:
    Cancer
    Date added:
    12/02/2021
    Date updated:
    12/02/2021
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Seagen
    Topic:
    Cancer
    Date added:
    12/02/2021
    Date updated:
    12/02/2021

Pages

Return to 2022 Summit on Cancer Health Disparities